Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$370,766,838
+$17,875,427 QoQ
Shares Held
15,397,294
+22.5% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#41
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 39%
Shared 0%
None 61%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FMR LLC holds $75,393,052,380 across 17 Drug Manufacturers - General names. PFE ranks #11 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,462,475 | $34,138,749,234 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
66,870,816 | $8,448,458,890 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,440,355 | $5,839,085,616 | |
| 4 | JNJ |
Johnson & Johnson
|
22,595,566 | $5,738,595,894 | |
| 5 | AZN |
Astrazeneca PLC
|
28,895,264 | $5,479,119,956 | |
| 6 | ABBV |
AbbVie Inc.
|
20,773,786 | $5,227,515,506 | |
| 7 | BIIB |
Biogen Inc.
|
18,217,239 | $3,936,016,655 | |
| 8 | GSK |
GSK plc
|
64,961,641 | $3,405,289,219 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $370,766,838 | 15,397,294 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $352,891,411 | 12,567,358 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $305,650,984 | 12,275,140 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $366,940,916 | 14,401,135 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $430,252,071 | 17,749,673 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $355,183,124 | 14,016,698 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $285,357,207 | 10,756,020 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $419,007,470 | 14,478,489 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $392,928,117 | 14,043,178 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $349,855,015 | 12,607,388 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $287,937,711 | 10,001,310 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $382,550,204 | 11,533,018 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $479,874,828 | 13,082,738 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $504,707,504 | 12,370,282 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $651,827,471 | 12,721,067 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $938,106,223 | 21,437,528 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,086,593,081 | 20,724,644 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $920,966,089 | 17,789,571 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $607,614,577 | 10,289,832 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $353,859,483 | 8,227,377 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $167,445,809 | 4,275,940 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $259,948,437 | 7,174,950 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $283,930,620 | 7,713,410 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $260,457,109 | 7,096,931 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $210,168,511 | 6,427,165 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $217,303,147 | 6,657,581 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||